A17.81 Tuberculoma of brain and spinal cord

Name of the Condition

• Tuberculoma of brain and spinal cord

Summary

Tuberculoma of the brain and spinal cord is a localized, granulomatous lesion caused by Mycobacterium tuberculosis infection within the central nervous system (CNS). These lesions typically form as a result of the body's immune response to the bacteria, leading to a mass-like structure that can affect neurological function. Prompt diagnosis and treatment are essential to prevent complications and reduce long-term disability.

Causes

Tuberculoma of the brain and spinal cord is caused by the spread of Mycobacterium tuberculosis from a primary infection, often in the lungs, to the CNS. The bacteria may reach the brain or spinal cord through the bloodstream or by direct extension from adjacent infected tissues. The formation of a tuberculoma represents a chronic, contained form of TB infection within the nervous system.

Risk Factors

• Active pulmonary tuberculosis or other extrapulmonary TB
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Malnutrition or chronic illness
• Recent TB exposure or infection
• Lack of access to TB treatment or preventive care

Symptoms

• Persistent headache
• Neurological deficits (e.g., weakness, numbness, confusion)
• Seizures
• Focal neurological signs (e.g., vision changes, motor impairment)
• Fever or systemic symptoms (less common)

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging (e.g., MRI or CT scans), and laboratory testing. Imaging typically reveals a well-defined, enhancing lesion consistent with a tuberculoma. Laboratory tests, including cerebrospinal fluid (CSF) analysis and microbiological studies, may help confirm the presence of Mycobacterium tuberculosis. Biopsy may be required in some cases to differentiate from other lesions.

Treatment Options

Treatment primarily involves a prolonged course of anti-tuberculosis medications, often including isoniazid, rifampin, pyrazinamide, and ethambutol. Corticosteroids may be used to reduce inflammation and manage symptoms. Surgical intervention is rarely needed but may be considered for lesions causing significant mass effect or neurological compromise.

Prognosis and Follow-Up

Prognosis depends on the size and location of the tuberculoma, as well as the timeliness of treatment. Most patients respond well to anti-TB therapy, with resolution of lesions over time. Follow-up imaging and clinical assessments are necessary to monitor treatment response and detect potential complications. Long-term neurological sequelae may occur in some cases.

Complications

• Neurological deficits (e.g., weakness, cognitive impairment)
• Seizures
• Increased intracranial pressure
• Hydrocephalus
• Recurrence of lesions if treatment is incomplete

Lifestyle & Prevention

• Adhere to prescribed anti-TB medication regimens to ensure complete treatment.
• Maintain a healthy immune system through proper nutrition and management of chronic conditions.
• Avoid exposure to individuals with active TB, especially if immunocompromised.
• Follow public health guidelines for TB prevention and screening.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden or worsening neurological symptoms (e.g., severe headache, confusion, weakness)
• Seizures
• Changes in mental status or consciousness
• Persistent fever or systemic symptoms

Tips for Medical Coders

When coding for tuberculoma of the brain and spinal cord, use ICD-10-CM code A17.81. Ensure documentation supports the diagnosis, including clinical findings, imaging results, and microbiological confirmation if available. Differentiate from other CNS lesions (e.g., tumors, abscesses) to avoid miscoding. Verify that the code aligns with the specific anatomical location (brain or spinal cord) and clinical presentation.